Cargando…

Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is an extremely malignant tumor that affects individuals throughout the world. One of the main causes of HCC is hepatitis B virus (HBV). Therefore, it is crucial to understand the mechanisms underlying HBV carcinogenesis. Increasing evidence suggests that the HBV X pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhuoran, Li, Nan, Cai, Peng, Zhang, Cunzhen, Cao, Guangwen, Yin, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517716/ https://www.ncbi.nlm.nih.gov/pubmed/37746253 http://dx.doi.org/10.3389/fonc.2023.1249198

Ejemplares similares

Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma
por: Ni, Zhengzhong, et al.
Publicado: (2021)

Autophagic Degradation of Misfolded Nuclear Receptor Co-repressor (NCoR) Is Linked to the Growth of Tumor Cells in HBX Positive Hepatocellular Carcinoma (HCC)
por: Tan, Su Yin, et al.
Publicado: (2019)

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma
por: Pu, Rui, et al.
Publicado: (2022)

A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
por: Qu, Siming, et al.
Publicado: (2021)

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, Ping, et al.
Publicado: (2023)

HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma
por: Huang, Jin-lan, et al.
Publicado: (2015)

The HBx–CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1
por: Li, Yajun, et al.
Publicado: (2019)

HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
por: Chen, Shi‐Lu, et al.
Publicado: (2017)

HBx Gene Mutations in Hepatitis B Virus and Hepatocellular Carcinoma
por: Mathew M, Anumol, et al.
Publicado: (2014)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

HBX-Mediated Migration of HBV-Replicating HepG2 Cells: Insights on Development of Hepatocellular Carcinoma
por: Feng, Huixing, et al.
Publicado: (2009)

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis
por: Banini, Bubu A., et al.
Publicado: (2022)

Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling
por: Chen, Lingjun, et al.
Publicado: (2022)

The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma
por: Schultheiss, Christina S., et al.
Publicado: (2017)

Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma
por: Liu, Yanping, et al.
Publicado: (2022)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
por: Xia, Haoming, et al.
Publicado: (2021)

Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma
por: Pan, Qi, et al.
Publicado: (2022)

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx
por: Murata, Takayuki, et al.
Publicado: (2023)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2022)

Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development
por: Yip, Wing-Kit, et al.
Publicado: (2011)

miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin
por: Chen, Wen-Shu, et al.
Publicado: (2015)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress
por: Wang, Ming-Da, et al.
Publicado: (2016)

HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
por: Chen, Jhen-Yu, et al.
Publicado: (2015)

HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis
por: Wang, Qing, et al.
Publicado: (2020)

Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
por: Medhat, Arvin, et al.
Publicado: (2021)

Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
por: McBrearty, Noreen, et al.
Publicado: (2021)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

Role of Tetraspanins in Hepatocellular Carcinoma
por: Cai, Sicheng, et al.
Publicado: (2021)

Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2019)

Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects
por: Lin, Xinrong, et al.
Publicado: (2021)

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
por: Zou, Yi, et al.
Publicado: (2021)

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2020)

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
por: Liu, L-p, et al.
Publicado: (2014)

USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells
por: Qian, Yu, et al.
Publicado: (2016)

HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma
por: Tsuchiya, Hiroyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgrcn7kkdgj4c6e2f7n5onki3m